-+ 0.00%
-+ 0.00%
-+ 0.00%

GALECTIN THERAPEUTICS INC - FY2025 NET LOSS APPLICABLE TO COMMON STOCKHOLDERS WAS $31.0 MLN, OR ($0.48) PER SHARE

Reuters·03/31/2026 12:00:08

Please log in to view news